"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Glenmark Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Glenn Saldanha
Home : Indian Private	Book Value: 848.3143291
BSE Code : 532296	Market Cap: 65607.46
NSE Code : GLENMARK	P / E : 44.22

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Type	3Qtr	2Qtr	1Qtr	4Qtr
Net Sales	2328.23	1219.53	2178.90	1909.94
Other Income	109.06	285.76	69.34	88.45
Total Income	2468.99	1824.42	2464.26	2097.95
Total Expenditure	2041.30	2648.45	1990.00	1848.13
Operating Profit	427.69	-824.04	474.26	249.81
Interest	21.98	23.40	15.46	13.13
Gross Profit	405.71	-847.43	458.80	236.68
Depreciation	59.18	58.93	57.64	55.53
Tax	0.00	-70.17	70.17	-25.62
Deferred Tax	64.46	-97.01	0.77	59.02
Reported Profit After Tax	282.07	-739.19	330.23	147.76

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView